ANELLOSCREEN
Dead / Abandoned — Abandoned — no statement of use filed (as of 16 Jun 2025)
What this means for you
This application is over — abandoned 16 Jun 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97269214
- Mark type
- Stylized text
- Filed
- 16 Feb 2022
- Published for opposition
- 21 Mar 2023
- Abandoned
- 16 Jun 2025
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 042 — Scientific and technological services: Scientific research and development related to the discovery of anelloviruses; scientific research and development services, namely, providing high throughput screening of anelloviruses for the capture and analysis of data and use in drug discovery; laboratory analysis in the field of anelloviruses; anellovirus screening for scientific research purposes; research and development of therapeutics related to anelloviruses; analysis of scientific and medical data in the field of anelloviruses
Owner
- Ring Therapeutics, Inc., Cambridge, MA, US
- Ring Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 16 Jun 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 16 Jun 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 25 Jan 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Jan 2025 — SOU EXTENSION 3 GRANTED
- 14 Nov 2024 — SOU EXTENSION 3 FILED
- 30 Dec 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 14 Nov 2024 — SOU TEAS EXTENSION RECEIVED
- 15 May 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 May 2024 — SOU EXTENSION 2 GRANTED
- 14 May 2024 — SOU EXTENSION 2 FILED
- 14 May 2024 — SOU TEAS EXTENSION RECEIVED
- 26 Dec 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 26 Dec 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 26 Dec 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 14 Nov 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED